These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 21838308

  • 1. Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line.
    Montazeri Aliabadi H, Landry B, Mahdipoor P, Uludağ H.
    Mol Pharm; 2011 Oct 03; 8(5):1821-30. PubMed ID: 21838308
    [Abstract] [Full Text] [Related]

  • 2. Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells.
    Aliabadi HM, Mahdipoor P, Uludağ H.
    Cancer Gene Ther; 2013 Mar 03; 20(3):169-77. PubMed ID: 23449477
    [Abstract] [Full Text] [Related]

  • 3. Effective down-regulation of breast cancer resistance protein (BCRP) by siRNA delivery using lipid-substituted aliphatic polymers.
    Aliabadi HM, Landry B, Mahdipoor P, Hsu CY, Uludağ H.
    Eur J Pharm Biopharm; 2012 May 03; 81(1):33-42. PubMed ID: 22311298
    [Abstract] [Full Text] [Related]

  • 4. Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells.
    Parmar MB, Arteaga Ballesteros BE, Fu T, K C RB, Montazeri Aliabadi H, Hugh JC, Löbenberg R, Uludağ H.
    J Biomed Mater Res A; 2016 Dec 03; 104(12):3031-3044. PubMed ID: 27465922
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
    Alshamsan A, Hamdy S, Samuel J, El-Kadi AO, Lavasanifar A, Uludağ H.
    Biomaterials; 2010 Feb 03; 31(6):1420-8. PubMed ID: 19913908
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.
    Ji ZJ, Wang JL, Chen L.
    Oncol Rep; 2015 Aug 03; 34(2):811-22. PubMed ID: 26080853
    [Abstract] [Full Text] [Related]

  • 15. Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer.
    Shen J, Yin Q, Chen L, Zhang Z, Li Y.
    Biomaterials; 2012 Nov 03; 33(33):8613-24. PubMed ID: 22910221
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. siRNA-mediated inhibition of survivin gene enhances the anti-cancer effect of etoposide in U-937 acute myeloid leukemia cells.
    Jafarlou M, Baradaran B, Shanehbandi D, Saedi TA, Jafarlou V, Ismail P, Othman F.
    Cell Mol Biol (Noisy-le-grand); 2016 May 30; 62(6):44-9. PubMed ID: 27262801
    [Abstract] [Full Text] [Related]

  • 19. Co-delivery of chemosensitizing siRNA and an anticancer agent via multiple monocomplexation-induced hydrophobic association.
    Lee E, Oh C, Kim IS, Kwon IC, Kim S.
    J Control Release; 2015 Jul 28; 210():105-14. PubMed ID: 25979325
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.